Testosterone Environment of Splenocytes Modifies the Steroidogenesis of Polycystic Ovary in Rats

Abstract

The functional relationship between the ovary and immune cells is well known. The modulation of ovarian steroidogenesis in adult rats with polycystic ovary (PCO) by secretions of cultured splenocytes treated with 10^-6 M testosterone or 10^-6 M testosterone plus 10^-4 M flutamide, an androgen receptor antagonist, was investigated. Polycystic ovary was induced by estradiol valerate (2 mg/rat). Polycystic ovary splenocyte secretions decreased the release of androstenedione from PCO ovaries in contrast to the effect of non-PCO splenocyte secretions. This decrease was associated with a significant decrease in androgen receptor and IL-12 mRNA expression in PCO splenocytes. When splenocytes were treated with testosterone, their conditioned media further decreased androstenedione release from the ovary and had a greater inhibitory effect on PCO ovary compared with non-PCO ovary. This effect was reversed by flutamide. Polycystic ovary splenocytes showed a decrease in IL-1β mRNA expression. Their secretions scarcely affected progesterone release from non-PCO ovaries but significantly stimulated progesterone release from PCO ovary by an androgen-independent mechanism. The differential steroidogenic ability of splenocyte secretions from PCO rats is associated with the in vitro testosterone environment. Polycystic ovary splenocytes might exert a protective action against PCO effects through their secretions by inducing a low androstenedione response from the ovary.

splenocytes - androgen receptor - testosterone - polycystic ovary - interleukins

References

• 1 Rouabhia M, Ghanmi Z, Chakir J, Othmane O, Deschaux P. Effect of luteotrophic hormone (LH) and thymosin on mitogen induced blast transformation of Balb/c mouse lymphoid cells.  Life Sci. 1990;  46 257-264
• 2 Weigent DA, Blalock JE. Associations between the neuroendocrine and immune systems.  J Leukoc Biol. 1995;  58 137-150
• 3 Han D, Denison MS, Tachibana H, Yamada K. Effects of estrogenic compounds on immunoglobulin production by mouse splenocytes.  Biol Pharm Bull. 2002;  25 1263-1267
• 4 Brannstrom M, Mayrhofer G, Roberston D. Localization of leukocytes subsets in the rat ovary during the preovulatory period.  Biol Reprod. 1993;  48 277-286
• 5 Calogero AE, Nicoletti F, Palumbo MA, Burrello N, Di-Mauro M, Lunetta M, Bendtzen K, Cianci A. Macrophage-derived cytokines in the follicular fluids of women with infertility due to immunological causes. Elevated levels of interleukin 6 and low levels of granulocyte-macrophage colony-stimulating factor.  Cytokine. 1998;  10 814-818
• 6 Franks S. Polycystic ovary syndrome.  N Engl J Med. 1995;  333 853-861
• 7 Komarowska H, Waœko R, Iwanik K, Majewski P, Rafiñska L, Warenik-Szymankiewicz A, Sowiñski J. Ghrelin ovarian cell expression in patients with polycystic ovary syndrome: an immunohistochemical evaluation.  Horm Metab Res. 2006;  38 783-788
• 8 Spritzer PM, Comim FV, Capp E, D’Avila A. Influence of leptin, androgens and insulin sensitivity on increased GH response to clonidine in lean patients with polycystic ovary syndrome.  Horm Metab Res. 2005;  37 94-98
• 9 Semenova II. Adrenergic innervation of ovaries in Stein-Leventhal syndrome.  Vestn Akad Med Nauk SSSR. 1969;  24 58-62
• 10 Barria A, Leyton V, Ojeda SR, Lara HE. Ovarian steroidal response to gonadotropins and beta-adrenergic stimulation is enhanced in polycystic ovarian syndrome. Role of the sympathetic innervation.  Endocrinology. 1993;  133 2696-2703
• 11 Lara HE, Dorfman M, Venegas M, Luza SM, Luna SL, Mayerhofer A, Guimaraes MA, Rosa E-Silva AA, Ramírez VD. Changes in sympathetic nerve activity of the mammalian ovary during a normal estrous cycle and polycystic ovary syndrome. Studies on norepinephrine release.  Microsc Res Tech. 2002;  59 495-502
• 12 Brawer JR, Muñoz J, Farookhi R. Development of the polycystic ovarian condition (PCO) in the estradiol valerate-treated rat.  Biol Reprod. 1986;  35 647-655
• 13 Nelson VL, Qin KN, Rosenfield RL, Wood JR, Penning TM, Legro RS, Strauss JF, MacAllister JM. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome.  J Clin Endocrinol Metab. 2001;  86 5925-5933
• 14 Nelson-Degrave VL, Wickenheisser JK, Hendricks KL, Asano T, Fujishiro M, Legro RS, Kimball SR, Strauss JF, MacAllister JM. Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome.  Mol Endocrinol. 2005;  19 379-390
• 15 Forneris M, Oliveros L, Aguado LI. Effect of secretion of splenocytes after superior ovarian nerve section on the ovarian steroidogenesis.  Neuroimmunomodulation. 1999;  6 293-299
• 16 Forneris M, Aguado LI, Oliveros L. A neuroimmune regulation at peripheral level on the steroidogenesis of polycystic ovary in rats.  Cell Mol Biol. 2003;  46 965-971
• 17 Liva SM, Voskuhl RR. Testosterone acts directly on CD4+T lymphocytes to increase IL-10 production.  J Immunol. 2001;  167 2060-2067
• 18 Oliveros L, Forneris M, Aguado L. Secretion from neuropeptide-treated splenocytes modifies the ovarian steroidogenesis.  Medicina (Bs As). 2001;  61 35-40
• 19 Tan JA, Joseph DR, Quarmby V, Lubahn D, Sar M, French F, Wilson EM. The rat androgen receptor: primary structure, autoregulation of its m ribonucleic acid, and immunocytochemical localization of the receptor protein.  Mol Endocrinol. 1988;  2 1276-1285
• 20 Okura Y, Takeda K, Honda S, Hanawa H, Watanabe H, Kodama M, Izumi T, Aizawa Y, Seki S, Abo T. Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats.  Circ Res. 1998;  82 1035-1042
• 21 Hansen MK, Taishi P, Chen Z, Krueger JM. Cafeteria feeding induces interleukin-1β mRNA expression in rat liver and brain.  Am J Physiol Regulatory Integrative Comp Physiol. 1998;  274 1734-1739
• 22 Gazvani MR, Bates M, Vince G, Christmas S, Lewis-Jones DI, Kingsland C. Follicular fluid concentrations of interleukin-12 and interleukin-8 in IVF cycles.  Fertil Steril. 2000;  74 953-958
• 23 Gallinelli A, Ciaccio I, Giannella L, Salvatori M, Marsella T, Volpe A. Correlations between concentrations of interleukin-12 and interleukin-13 and lymphocyte subsets in the follicular fluid of women with and without polycystic ovary syndrome.  Fertil Steril. 2003;  79 1365-1372
• 24 Benten WP, Becker A, Schmitt-Wredw HP, Wunderlich F. Developmental regulation of intracellular and surface androgen receptors in T cells.  Steroids. 2002;  67 925-931
• 25 Best C, Hill J. Interleukin-1 and -β modulation of luteinized human granulosa cell oestrogen and progesterone biosynthesis.  Hum Reprod. 1995;  10 3206-3210
• 26 Hurwitz A, Finci-Yeheskel Z, Yagel S, Shimonovitz S, Laufer N, Adashi EY, Mayer M. Interleukin-1 beta inhibits progesterone accumulation in rat corpora luteal cell cultures in a mechanism dissociated from its effects on nitric oxide and prostaglandin E accumulation.  Mol Cell Endocrinol. 1997;  133 41-48
• 27 Turi A, Di Prospero F, Mazzarini A, Costa M, Cignitti M, Garzetti GG, Romanini C. Lymphocytes subset in hyperandrogenic women with polycystic ovarian disease.  Act Eur Fert. 1988;  19 155-157
• 28 Straub RH, Mayer M, Kreutz M, Leeb S, Scholmerich J, Falk W. Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractans for monocytes.  J Leukoc Biol. 2000;  67 553-558
• 29 García-Velasco JA, Arici A. Chemokines and human reproduction.  Fertil Steril. 1999;  71 983-993
• 30 Rivier C. Influence of immune signals on the hypothalamic-pituitary axis of the rodent.  Front Neuroendocrin. 1995;  16 151-182

Correspondence